David Cypcar
Allergy & Immunology · Asheville, NCNPI 1508857319
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Optinose US, Inc. at 57.1% of the total. Reporting peaked in 2019 at $16,689 and has fallen 92.5% since, to $1,256 in 2025.
Across 386 payments — averaging $104.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$23K
- Boehringer Ingelheim$5K
- Novartis$4K
- Alk-abello, Inc$2K
- AstraZeneca$1K
- GSK$1K
- plus $4K from 18 others
Across 192 payments — averaging $7984.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$953K
- GSK$225K
- Novartis$100K
- Hikma Pharmaceuticals USA$76K
- Regeneron$60K
- Teva Pharmaceuticals USA, Inc.$44K
- plus $75K from 4 others
What the payments were for
- Consulting fees$5,13613%
- Speaking & faculty fees$20,95552%
- Travel & lodging$5,58814%
- Food & beverage$8,67121%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 58 | $23,056 |
| Boehringer Ingelheim | 12 | $5,384 |
| Novartis | 16 | $4,323 |
| Alk-abello, Inc | 28 | $1,661 |
| AstraZeneca | 41 | $1,231 |
| GSK | 51 | $1,212 |
| CSL Behring | 23 | $603 |
| Sanofi | 18 | $444 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $438 |
| Pfizer | 30 | $354 |
| Biocryst US Sales Co., LLC | 12 | $269 |
| Genentech USA, Inc. | 10 | $256 |
| Regeneron Healthcare Solutions, Inc. | 10 | $201 |
| Grifols USA, LLC | 6 | $168 |
| Kaleo, Inc. | 9 | $153 |
| Pharming Healthcare, Inc. | 7 | $141 |
| Hospira, Inc. | 7 | $139 |
| Amgen(2 entities) | 7 | $125 |
| Teva Pharmaceuticals USA, Inc. | 8 | $122 |
| Covis Pharma GmbH | 2 | $26 |
| Shire North American Group Inc | 1 | $17 |
| Circassia Inc. | 1 | $16 |
| Biocryst Pharmaceuticals, Inc. | 1 | $16 |
| Octapharma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,369 in reported general payments places this provider in the 85th percentile of 140 allergy & immunology providers in North Carolina.
Other allergy & immunology in Asheville
- William McCannAsheville$486K
- David BrownAsheville$129K
- Christopher CopenhaverAsheville$88K
- Elise CoulsonAsheville$16K
- Jordan SmallwoodAsheville$13K
- John van WyeAsheville$11K
- Catherine CranfordAsheville$7K
- Maeve OconnorCharlotte$2.2M
- Joel HartmanWinston Salem$749K
- Cristine RadojicicDurham$558K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.